{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:32:43Z","timestamp":1720611163058},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/s0213-005x(11)70053-2","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T17:15:33Z","timestamp":1369934133000},"page":"24-27","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S6","title":["Estudios de resistencia. \u00bfCu\u00e1ndo est\u00e1n indicados?"],"prefix":"10.1016","volume":"29","author":[{"given":"M.","family":"\u00c1ngeles Marcos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0213-005X(11)70053-2_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/338143","article-title":"High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy","volume":"185","author":"Limaye","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-0012.2007.00761.x","article-title":"Emergence of drugresistance cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcome","volume":"22","author":"Eid","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/S0213-005X(11)70053-2_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/135965350901400512","article-title":"Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir","volume":"14","author":"Bouvin","year":"2009","journal-title":"Antiviral Therapy"},{"key":"10.1016\/S0213-005X(11)70053-2_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S0213-005X(11)70053-2_bib5","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(11)70053-2_bib6","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"97","author":"Emery","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0213-005X(11)70053-2_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-3062.2002.t01-1-02008.x","article-title":"Clinical characteristics of 13 solid organ transplant recipients with ganciclovirresistant cytomegalovirus infection","volume":"4","author":"Isada","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-3062.2005.00112.x","article-title":"Clinical impact of ganciclovirresistant cytomegalovirus infections in solid organ transplant patients","volume":"7","author":"Bouvin","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/rmv.558","article-title":"Human cytomegalovirus DNA replication: antiviral targets and drugs","volume":"18","author":"Mercorelli","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/S0213-005X(11)70053-2_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL 97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogenic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0213-005X(11)70053-2_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1086\/514339","article-title":"Relationship between toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation","volume":"44","author":"Kijpittayarit","year":"2007","journal-title":"Cllin Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib13","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.TP.0000164512.99703.AD","article-title":"Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients","volume":"79","author":"Wiltshire","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/S0213-005X(11)70053-2_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jchromb.2006.10.053","article-title":"A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC\/MS\/MS","volume":"848","author":"Xu","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/S0213-005X(11)70053-2_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob agents Chemother"},{"key":"10.1016\/S0213-005X(11)70053-2_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcv.2011.01.004","article-title":"Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy","volume":"50","author":"Chou","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/S0213-005X(11)70053-2_bib17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.48.5.1865-1868.2004","article-title":"Natural polymorphism of cytomegalovirus DNA poymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I","volume":"48","author":"Fillet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(11)70053-2_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/AAC.49.3.873-883.2005","article-title":"Human cytomegalovirus resistance to antiviral drugs","volume":"49","author":"Gilbert","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(11)70053-2_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/135965350801300308","article-title":"Rapid semiquantitative realtime PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance","volume":"13","author":"G\u00f6hring","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/S0213-005X(11)70053-2_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/340101","article-title":"Combination antiviral therapy for ganciclovirresistant cytomegalovirus infection in solid-organ transplant recipients","volume":"34","author":"Mylonakis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bmt.1703666","article-title":"Rapid development of ganciclovir-resistant cytomegalovirus infection in childrenafter allogeneic stem cell cell transplantation in the early phase of immune cell recovery","volume":"30","author":"Eckle","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0213-005X(11)70053-2_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1399-0012.2007.00699.x","article-title":"The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients","volume":"21","author":"Ozaki","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/S0213-005X(11)70053-2_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/S0213-005X(11)70053-2_bib24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/653122","article-title":"Virologic characterization of multidrug-resistant cytomegalovirus infection in transplant recipients treated with maribavir","volume":"202","author":"Strasfeld","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/S0213-005X(11)70053-2_bib26","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.78.13.7124-7130.2004","article-title":"Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir","volume":"78","author":"Chou","year":"2004","journal-title":"J Virol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11700532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11700532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T21:21:33Z","timestamp":1688246493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X11700532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"alternative-id":["S0213005X11700532"],"URL":"https:\/\/doi.org\/10.1016\/s0213-005x(11)70053-2","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}